139 related articles for article (PubMed ID: 37463778)
21. Three different intraoperative radiation modalities (electron beam, high-dose-rate brachytherapy, and iodine-125 brachytherapy) in the adjuvant treatment of patients with recurrent colorectal adenocarcinoma.
Martínez-Monge R; Nag S; Martin EW
Cancer; 1999 Jul; 86(2):236-47. PubMed ID: 10421259
[TBL] [Abstract][Full Text] [Related]
22. Muscle invasive bladder cancer treated by transurethral resection, followed by external beam radiation and interstitial iridium-192.
Wijnmaalen A; Helle PA; Koper PC; Jansen PP; Hanssens PE; Boeken Kruger CG; van Putten WL
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1043-52. PubMed ID: 9392543
[TBL] [Abstract][Full Text] [Related]
23. Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer.
Merrick GS; Butler WM; Galbreath RW; Lief JH
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):41-8. PubMed ID: 11516849
[TBL] [Abstract][Full Text] [Related]
24. Outcomes after photoselective vaporization of the prostate and transurethral resection of the prostate in patients who develop prostatic obstruction after radiation therapy.
Abelson B; Reddy CA; Ciezki JP; Angermeier K; Ulchaker J; Klein EA; Wood HM
Urology; 2014 Feb; 83(2):422-7. PubMed ID: 24315301
[TBL] [Abstract][Full Text] [Related]
25. External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patients.
van Onna IE; Oddens JR; Kok ET; van Moorselaar RJ; Bosch JL; Battermann JJ
Eur Urol; 2009 Jul; 56(1):113-21. PubMed ID: 18722048
[TBL] [Abstract][Full Text] [Related]
26. Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate.
Lawton CA; Yan Y; Lee WR; Gillin M; Firat S; Baikadi M; Crook J; Kuettel M; Morton G; Sandler H
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e795-801. PubMed ID: 22330999
[TBL] [Abstract][Full Text] [Related]
27. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
[TBL] [Abstract][Full Text] [Related]
28. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
Hurwitz MD; Halabi S; Ou SS; McGinnis LS; Keuttel MR; Dibiase SJ; Small EJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):814-9. PubMed ID: 18407435
[TBL] [Abstract][Full Text] [Related]
29. Contracted bladder developing after prostate brachytherapy.
Yamada Y; Minowada S; Aruga T; Homma Y
Int J Urol; 2012 Oct; 19(10):951-3. PubMed ID: 22725658
[TBL] [Abstract][Full Text] [Related]
30. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
MacDonald OK; Schild SE; Vora S; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW
Urology; 2004 Oct; 64(4):760-4. PubMed ID: 15491716
[TBL] [Abstract][Full Text] [Related]
31. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
32. Clinical and treatment characteristics of secondary bladder malignancies following low dose rate brachytherapy for prostate cancer.
Chin CP; Smith WH; Cesaretti J; Terk M; Garden EB; Araya JS; Palese MA; Stock RG; Buckstein M
Urol Oncol; 2023 Jun; 41(6):296.e9-296.e16. PubMed ID: 36588020
[TBL] [Abstract][Full Text] [Related]
33. HDR monotherapy for man with radiotherapy contraindications and prostate cancer.
Lo A; Nam RK; Loblaw A
Can J Urol; 2011 Aug; 18(4):5839-43. PubMed ID: 21854718
[TBL] [Abstract][Full Text] [Related]
34. Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning.
Hathout L; Folkert MR; Kollmeier MA; Yamada Y; Cohen GN; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):312-9. PubMed ID: 25304791
[TBL] [Abstract][Full Text] [Related]
35. Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.
Wedde TB; Småstuen MC; Brabrand S; Fosså SD; Kaasa S; Tafjord G; Russnes KM; Hellebust TP; Lilleby W
Radiother Oncol; 2019 Mar; 132():211-217. PubMed ID: 30389241
[TBL] [Abstract][Full Text] [Related]
36. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
37. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience.
Jabbari S; Hsu IC; Kawakami J; Weinberg VK; Speight JL; Gottschalk AR; Roach M; Shinohara K
Brachytherapy; 2009; 8(4):339-44. PubMed ID: 19428310
[TBL] [Abstract][Full Text] [Related]
38. [A CASE OF PROSTATE CANCER WITH UNUSUAL PATTERN OF RECURRENCE AFTER RADIOTHERAPY].
Oshinomi K; Fukagai T; Ogawa Y; Sato N; Morita J; Aso T; Igarashi A; Morita M; Naoe M; Fuji K; Ogawa Y
Nihon Hinyokika Gakkai Zasshi; 2015 Jan; 106(1):40-4. PubMed ID: 26399130
[TBL] [Abstract][Full Text] [Related]
39. Dose escalation with external beam radiation therapy and high-dose-rate brachytherapy combined with long-term androgen deprivation therapy in high and very high risk prostate cancer: Comparison of two consecutive high-dose-rate schemes.
Olarte A; Cambeiro M; Moreno-Jiménez M; Arbea L; Pérez-Gracia JL; Gil-Bazo I; Pascual I; Aristu J; Martínez-Monge R
Brachytherapy; 2016; 15(2):127-35. PubMed ID: 26832677
[TBL] [Abstract][Full Text] [Related]
40. Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter.
Blank LE; Koedooder K; van Os R; van de Kar M; van der Veen JH; Koning CC
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):454-8. PubMed ID: 17560734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
